LncRNAs作为自噬涉及的心血管疾病的治疗靶点：分子机制和治疗策略的审查。

McClellan, M.; Brown, N.; Califf, R.M.; Warner, J.J. Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American heart association. Circulation, 2019, 139(9), e44-e54.
[http://dx.doi.org/10.1161/CIR.0000000000000652] [PMID: 30674212]

Roth, G.A.; Johnson, C.; Abajobir, A.; Abd-Allah, F.; Abera, S.F.; Abyu, G.; Ahmed, M.; Aksut, B.; Alam, T.; Alam, K.; Alla, F.; Alvis-Guzman, N.; Amrock, S.; Ansari, H.; Ärnlöv, J.; Asayesh, H.; Atey, T.M.; Avila-Burgos, L.; Awasthi, A.; Banerjee, A.; Barac, A.; Bärnighausen, T.; Barregard, L.; Bedi, N.; Belay Ketema, E.; Bennett, D.; Berhe, G.; Bhutta, Z.; Bitew, S.; Carapetis, J.; Carrero, J.J.; Malta, D.C.; Castañeda-Orjuela, C.A.; Castillo-Rivas, J.; Catalá-López, F.; Choi, J.Y.; Christensen, H.; Cirillo, M.; Cooper, L., Jr; Criqui, M.; Cundiff, D.; Damasceno, A.; Dandona, L.; Dandona, R.; Davletov, K.; Dharmaratne, S.; Dorairaj, P.; Dubey, M.; Ehrenkranz, R.; El Sayed Zaki, M.; Faraon, E.J.A.; Esteghamati, A.; Farid, T.; Farvid, M.; Feigin, V.; Ding, E.L.; Fowkes, G.; Gebrehiwot, T.; Gillum, R.; Gold, A.; Gona, P.; Gupta, R.; Habtewold, T.D.; Hafezi-Nejad, N.; Hailu, T.; Hailu, G.B.; Hankey, G.; Hassen, H.Y.; Abate, K.H.; Havmoeller, R.; Hay, S.I.; Horino, M.; Hotez, P.J.; Jacobsen, K.; James, S.; Javanbakht, M.; Jeemon, P.; John, D.; Jonas, J.; Kalkonde, Y.; Karimkhani, C.; Kasaeian, A.; Khader, Y.; Khan, A.; Khang, Y.H.; Khera, S.; Khoja, A.T.; Khubchandani, J.; Kim, D.; Kolte, D.; Kosen, S.; Krohn, K.J.; Kumar, G.A.; Kwan, G.F.; Lal, D.K.; Larsson, A.; Linn, S.; Lopez, A.; Lotufo, P.A.; El Razek, H.M.A.; Malekzadeh, R.; Mazidi, M.; Meier, T.; Meles, K.G.; Mensah, G.; Meretoja, A.; Mezgebe, H.; Miller, T.; Mirrakhimov, E.; Mohammed, S.; Moran, A.E.; Musa, K.I.; Narula, J.; Neal, B.; Ngalesoni, F.; Nguyen, G.; Obermeyer, C.M.; Owolabi, M.; Patton, G.; Pedro, J.; Qato, D.; Qorbani, M.; Rahimi, K.; Rai, R.K.; Rawaf, S.; Ribeiro, A.; Safiri, S.; Salomon, J.A.; Santos, I.; Santric Milicevic, M.; Sartorius, B.; Schutte, A.; Sepanlou, S.; Shaikh, M.A.; Shin, M.J.; Shishehbor, M.; Shore, H.; Silva, D.A.S.; Sobngwi, E.; Stranges, S.; Swaminathan, S.; Tabarés-Seisdedos, R.; Tadele Atnafu, N.; Tesfay, F.; Thakur, J.S.; Thrift, A.; Topor-Madry, R.; Truelsen, T.; Tyrovolas, S.; Ukwaja, K.N.; Uthman, O.; Vasankari, T.; Vlassov, V.; Vollset, S.E.; Wakayo, T.; Watkins, D.; Weintraub, R.; Werdecker, A.; Westerman, R.; Wiysonge, C.S.; Wolfe, C.; Workicho, A.; Xu, G.; Yano, Y.; Yip, P.; Yonemoto, N.; Younis, M.; Yu, C.; Vos, T.; Naghavi, M.; Murray, C. Global, regional and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J. Am. Coll. Cardiol., 2017, 70(1), 1-25.
[http://dx.doi.org/10.1016/j.jacc.2017.04.052] [PMID: 28527533]

Picca, A.; Mankowski, R.T.; Burman, J.L.; Donisi, L.; Kim, J.S.; Marzetti, E.; Leeuwenburgh, C. Mitochondrial quality control mechanisms as molecular targets in cardiac ageing. Nat. Rev. Cardiol., 2018, 15(9), 543-554.
[http://dx.doi.org/10.1038/s41569-018-0059-z] [PMID: 30042431]

Bonora, M.; Wieckowski, M.R.; Sinclair, D.A.; Kroemer, G.; Pinton, P.; Galluzzi, L. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nat. Rev. Cardiol., 2019, 16(1), 33-55.
[http://dx.doi.org/10.1038/s41569-018-0074-0] [PMID: 30177752]

Wang, J.; Liu, S.; Heallen, T.; Martin, J.F. The Hippo pathway in the heart: pivotal roles in development, disease and regeneration. Nat. Rev. Cardiol., 2018, 15(11), 672-684.
[http://dx.doi.org/10.1038/s41569-018-0063-3] [PMID: 30111784]

Napoletano, F.; Baron, O.; Vandenabeele, P.; Mollereau, B.; Fanto, M. Intersections between regulated cell death and autophagy. Trends Cell Biol., 2019, 29(4), 323-338.
[http://dx.doi.org/10.1016/j.tcb.2018.12.007] [PMID: 30665736]

Mialet-Perez, J.; Vindis, C. Autophagy in health and disease: focus on the cardiovascular system. Essays Biochem., 2017, 61(6), 721-732.
[http://dx.doi.org/10.1042/EBC20170022] [PMID: 29233881]

Bravo-San Pedro, J.M.; Kroemer, G.; Galluzzi, L. Autophagy and mitophagy in cardiovascular disease. Circ. Res., 2017, 120(11), 1812-1824.
[http://dx.doi.org/10.1161/CIRCRESAHA.117.311082] [PMID: 28546358]

Galluzzi, L.; Bravo-San Pedro, J.M.; Levine, B.; Green, D.R.; Kroemer, G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat. Rev. Drug Discov., 2017, 16(7), 487-511.
[http://dx.doi.org/10.1038/nrd.2017.22] [PMID: 28529316]

Hobuß, L.; Bär, C.; Thum, T. Long non-coding RNAs: at the heart of cardiac dysfunction? Front. Physiol., 2019, 10, 30.
[http://dx.doi.org/10.3389/fphys.2019.00030] [PMID: 30761015]

Lee, H.; Zhang, Z.; Krause, H.M. Long noncoding RNAs and repetitive elements: junk or intimate evolutionary partners? Trends Genet., 2019, 35(12), 892-902.
[http://dx.doi.org/10.1016/j.tig.2019.09.006] [PMID: 31662190]

Derrien, T.; Johnson, R.; Bussotti, G.; Tanzer, A.; Djebali, S.; Tilgner, H.; Guernec, G.; Martin, D.; Merkel, A.; Knowles, D.G.; Lagarde, J.; Veeravalli, L.; Ruan, X.; Ruan, Y.; Lassmann, T.; Carninci, P.; Brown, J.B.; Lipovich, L.; Gonzalez, J.M.; Thomas, M.; Davis, C.A.; Shiekhattar, R.; Gingeras, T.R.; Hubbard, T.J.; Notredame, C.; Harrow, J.; Guigó, R. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution and expression. Genome Res., 2012, 22(9), 1775-1789.
[http://dx.doi.org/10.1101/gr.132159.111] [PMID: 22955988]

Quinodoz, S.; Guttman, M. Long noncoding RNAs: an emerging link between gene regulation and nuclear organization. Trends Cell Biol., 2014, 24(11), 651-663.
[http://dx.doi.org/10.1016/j.tcb.2014.08.009] [PMID: 25441720]

Yang, L.; Wang, H.; Shen, Q.; Feng, L.; Jin, H. Long non-coding RNAs involved in autophagy regulation. Cell Death Dis., 2017, 8(10), e3073.
[http://dx.doi.org/10.1038/cddis.2017.464] [PMID: 28981093]

Barangi, S.; Hayes, A.W.; Reiter, R.; Karimi, G. The therapeutic role of long non-coding RNAs in human diseases: A focus on the recent insights into autophagy. Pharmacol. Res., 2019, 142, 22-29.
[http://dx.doi.org/10.1016/j.phrs.2019.02.010] [PMID: 30742900]

Liu, C.Y.; Zhang, Y.H.; Li, R.B.; Zhou, L.Y.; An, T.; Zhang, R.C.; Zhai, M.; Huang, Y.; Yan, K.W.; Dong, Y.H.; Ponnusamy, M.; Shan, C.; Xu, S.; Wang, Q.; Zhang, Y.H.; Zhang, J.; Wang, K. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat. Commun., 2018, 9(1), 29.
[http://dx.doi.org/10.1038/s41467-017-02280-y] [PMID: 29295976]

Guo, F.X.; Wu, Q.; Li, P.; Zheng, L.; Ye, S.; Dai, X.Y.; Kang, C.M.; Lu, J.B.; Xu, B.M.; Xu, Y.J.; Xiao, L.; Lu, Z.F.; Bai, H.L.; Hu, Y.W.; Wang, Q. The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling. Cell Death Differ., 2019, 26(9), 1670-1687.
[http://dx.doi.org/10.1038/s41418-018-0235-z] [PMID: 30683918]

Viereck, J.; Kumarswamy, R.; Foinquinos, A.; Xiao, K.; Avramopoulos, P.; Kunz, M.; Dittrich, M.; Maetzig, T.; Zimmer, K.; Remke, J.; Just, A.; Fendrich, J.; Scherf, K.; Bolesani, E.; Schambach, A.; Weidemann, F.; Zweigerdt, R.; de Windt, L.J.; Engelhardt, S.; Dandekar, T.; Batkai, S.; Thum, T. Long noncoding RNA Chast promotes cardiac remodeling. Sci. Transl. Med., 2016, 8(326), 326ra22.
[http://dx.doi.org/10.1126/scitranslmed.aaf1475] [PMID: 26888430]

Liu, X.; Xiao, Z.D.; Han, L.; Zhang, J.; Lee, S.W.; Wang, W.; Lee, H.; Zhuang, L.; Chen, J.; Lin, H.K.; Wang, J.; Liang, H.; Gan, B. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat. Cell Biol., 2016, 18(4), 431-442.
[http://dx.doi.org/10.1038/ncb3328] [PMID: 26999735]

Liu, X.; Xiao, Z.D.; Gan, B. An lncRNA switch for AMPK activation. Cell Cycle, 2016, 15(15), 1948-1949.
[http://dx.doi.org/10.1080/15384101.2016.1184515] [PMID: 27152502]

Qiao, E.; Chen, D.; Li, Q.; Feng, W.; Yu, X.; Zhang, X.; Xia, L.; Jin, J.; Yang, H. Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57KIP2 and involving in p-p38 MAPK and NF-κB pathways. J. Cell. Biochem., 2019, 120(3), 3978-3988.
[http://dx.doi.org/10.1002/jcb.27680] [PMID: 30378143]

Chen, J.F.; Wu, P.; Xia, R.; Yang, J.; Huo, X.Y.; Gu, D.Y.; Tang, C.J.; De, W.; Yang, F. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy. Mol. Cancer, 2018, 17(1), 6.
[http://dx.doi.org/10.1186/s12943-017-0756-y] [PMID: 29329543]

Zheng, Y.; Tan, K.; Huang, H. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in colorectal cancer cells via sponging miR-100 to target ATG5 expression. J. Cell. Biochem., 2019, 120(3), 3922-3933.
[http://dx.doi.org/10.1002/jcb.27676] [PMID: 30430634]

Liu, M.; Han, T.; Shi, S.; Chen, E. Long noncoding RNA HAGLROS regulates cell apoptosis and autophagy in lipopolysaccharides-induced WI-38 cells via modulating miR-100/NF-κB axis. Biochem. Biophys. Res. Commun., 2018, 500(3), 589-596.
[http://dx.doi.org/10.1016/j.bbrc.2018.04.109] [PMID: 29673591]

Chen, Z.H.; Wang, W.T.; Huang, W.; Fang, K.; Sun, Y.M.; Liu, S.R.; Luo, X.Q.; Chen, Y.Q. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway. Cell Death Differ., 2017, 24(2), 212-224.
[http://dx.doi.org/10.1038/cdd.2016.111] [PMID: 27740626]

Egan, D.F.; Shackelford, D.B.; Mihaylova, M.M.; Gelino, S.; Kohnz, R.A.; Mair, W.; Vasquez, D.S.; Joshi, A.; Gwinn, D.M.; Taylor, R.; Asara, J.M.; Fitzpatrick, J.; Dillin, A.; Viollet, B.; Kundu, M.; Hansen, M.; Shaw, R.J. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science, 2011, 331(6016), 456-461.
[http://dx.doi.org/10.1126/science.1196371] [PMID: 21205641]

Lu, W.; Han, L.; Su, L.; Zhao, J.; Zhang, Y.; Zhang, S.; Zhao, B.; Miao, J.A. 3'UTR-associated RNA, FLJ11812 maintains stemness of human embryonic stem cells by targeting miR-4459. Stem Cells Dev., 2015, 24(9), 1133-1140.
[http://dx.doi.org/10.1089/scd.2014.0353] [PMID: 25437332]

Deng, X.; Feng, N.; Zheng, M.; Ye, X.; Lin, H.; Yu, X.; Gan, Z.; Fang, Z.; Zhang, H.; Gao, M.; Zheng, Z.J.; Yu, H.; Ding, W.; Qian, B. PM2.5 exposure-induced autophagy is mediated by lncRNA loc146880 which also promotes the migration and invasion of lung cancer cells. Biochim. Biophys. Acta, Gen. Subj., 2017, 1861(2), 112-125.
[http://dx.doi.org/10.1016/j.bbagen.2016.11.009] [PMID: 27836757]

Song, J.; Ahn, C.; Chun, C.H.; Jin, E.J. A long non-coding RNA, GAS5, plays a critical role in the regulation of miR-21 during osteoarthritis. J. Orthop. Res., 2014, 32(12), 1628-1635.
[http://dx.doi.org/10.1002/jor.22718] [PMID: 25196583]

Liu, Z.; Wei, X.; Zhang, A.; Li, C.; Bai, J.; Dong, J. Long non-coding RNA HNF1A-AS1 functioned as an oncogene and autophagy promoter in hepatocellular carcinoma through sponging hsa-miR-30b-5p. Biochem. Biophys. Res. Commun., 2016, 473(4), 1268-1275.
[http://dx.doi.org/10.1016/j.bbrc.2016.04.054] [PMID: 27084450]

Ma, B.; Yuan, Z.; Zhang, L.; Lv, P.; Yang, T.; Gao, J.; Pan, N.; Wu, Q.; Lou, J.; Han, C.; Zhang, B. Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy. Biochim. Biophys. Acta Mol. Cell Res., 2017, 1864(8), 1393-1404.
[http://dx.doi.org/10.1016/j.bbamcr.2017.05.008] [PMID: 28499919]

Wakatsuki, S.; Tokunaga, S.; Shibata, M.; Araki, T. GSK3B-mediated phosphorylation of MCL1 regulates axonal autophagy to promote Wallerian degeneration. J. Cell Biol., 2017, 216(2), 477-493.
[http://dx.doi.org/10.1083/jcb.201606020] [PMID: 28053206]

Tang, B.; Bao, N.; He, G.; Wang, J. Long noncoding RNA HOTAIR regulates autophagy via the miR-20b-5p/ATG7 axis in hepatic ischemia/reperfusion injury. Gene, 2019, 686, 56-62.
[http://dx.doi.org/10.1016/j.gene.2018.10.059] [PMID: 30367982]

Bao, X.; Ren, T.; Huang, Y.; Sun, K.; Wang, S.; Liu, K.; Zheng, B.; Guo, W. Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth. Cell Death Dis., 2017, 8(2), e2605.
[http://dx.doi.org/10.1038/cddis.2017.31] [PMID: 28182000]

Tsai, M.C.; Manor, O.; Wan, Y.; Mosammaparast, N.; Wang, J.K.; Lan, F.; Shi, Y.; Segal, E.; Chang, H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science, 2010, 329(5992), 689-693.
[http://dx.doi.org/10.1126/science.1192002] [PMID: 20616235]

Ge, D.; Han, L.; Huang, S.; Peng, N.; Wang, P.; Jiang, Z.; Zhao, J.; Su, L.; Zhang, S.; Zhang, Y.; Kung, H.; Zhao, B.; Miao, J. Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells. Autophagy, 2014, 10(6), 957-971.
[http://dx.doi.org/10.4161/auto.28363] [PMID: 24879147]

Chen, S.; Wu, D.D.; Sang, X.B.; Wang, L.L.; Zong, Z.H.; Sun, K.X.; Liu, B.L.; Zhao, Y. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma. Cell Death Dis., 2017, 8(10), e3118.
[http://dx.doi.org/10.1038/cddis.2017.486] [PMID: 29022892]

Li, L.; Chen, H.; Gao, Y.; Wang, Y.W.; Zhang, G.Q.; Pan, S.H.; Ji, L.; Kong, R.; Wang, G.; Jia, Y.H.; Bai, X.W.; Sun, B. Long noncoding RNA MALAT1 promotes aggressive pancreatic cancer proliferation and metastasis via the stimulation of autophagy. Mol. Cancer Ther., 2016, 15(9), 2232-2243.
[http://dx.doi.org/10.1158/1535-7163.MCT-16-0008] [PMID: 27371730]

Porrello, E.R.; Mahmoud, A.I.; Simpson, E.; Hill, J.A.; Richardson, J.A.; Olson, E.N.; Sadek, H.A. Transient regenerative potential of the neonatal mouse heart. Science, 2011, 331(6020), 1078-1080.
[http://dx.doi.org/10.1126/science.1200708] [PMID: 21350179]

Kalogeris, T.; Baines, C.P.; Krenz, M.; Korthuis, R.J. Cell biology of ischemia/reperfusion injury. Int. Rev. Cell Mol. Biol., 2012, 298, 229-317.
[http://dx.doi.org/10.1016/B978-0-12-394309-5.00006-7] [PMID: 22878108]

Wang, K.; Liu, C.Y.; Zhou, L.Y.; Wang, J.X.; Wang, M.; Zhao, B.; Zhao, W.K.; Xu, S.J.; Fan, L.H.; Zhang, X.J.; Feng, C.; Wang, C.Q.; Zhao, Y.F.; Li, P.F. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat. Commun., 2015, 6, 6779.
[http://dx.doi.org/10.1038/ncomms7779] [PMID: 25858075]

Yin, G.; Yang, X.; Li, Q.; Guo, Z. GATA1 activated lncRNA (Galont) promotes anoxia/reoxygenation-induced autophagy and cell death in cardiomyocytes by sponging miR-338. J. Cell. Biochem., 2018, 119(5), 4161-4169.
[http://dx.doi.org/10.1002/jcb.26623] [PMID: 29247537]

Chen, Z.; Jia, S.; Li, D.; Cai, J.; Tu, J.; Geng, B.; Guan, Y.; Cui, Q.; Yang, J. Silencing of long noncoding RNA AK139328 attenuates ischemia/reperfusion injury in mouse livers. PLoS One, 2013, 8(11), e80817.
[http://dx.doi.org/10.1371/journal.pone.0080817] [PMID: 24312245]

Yu, S.Y.; Dong, B.; Fang, Z.F.; Hu, X.Q.; Tang, L.; Zhou, S.H. Knockdown of lncRNA AK139328 alleviates myocardial ischaemia/reperfusion injury in diabetic mice via modulating miR-204-3p and inhibiting autophagy. J. Cell. Mol. Med., 2018, 22(10), 4886-4898.
[http://dx.doi.org/10.1111/jcmm.13754] [PMID: 30047214]

Ma, M.; Hui, J.; Zhang, Q.Y.; Zhu, Y.; He, Y.; Liu, X.J. Long non-coding RNA nuclear-enriched abundant transcript 1 inhibition blunts myocardial ischemia reperfusion injury via autophagic flux arrest and apoptosis in streptozotocin-induced diabetic rats. Atherosclerosis, 2018, 277, 113-122.
[http://dx.doi.org/10.1016/j.atherosclerosis.2018.08.031] [PMID: 30205319]

Guo, X.; Wu, X.; Han, Y.; Tian, E.; Cheng, J. LncRNA MALAT1 protects cardiomyocytes from isoproterenol-induced apoptosis through sponging miR-558 to enhance ULK1-mediated protective autophagy. J. Cell. Physiol., 2019, 234(7), 10842-10854.
[http://dx.doi.org/10.1002/jcp.27925] [PMID: 30536615]

Zhang, C.; Pan, S.; Aisha, A.; Abudoukelimu, M.; Tang, L.; Ling, Y. Recombinant human brain natriuretic peptide regulates PI3K/AKT/mTOR pathway through lncRNA EGOT to attenuate hypoxia-induced injury in H9c2 cardiomyocytes. Biochem. Biophys. Res. Commun., 2018, 503(3), 1186-1193.
[http://dx.doi.org/10.1016/j.bbrc.2018.07.023] [PMID: 30031611]

Nakamura, M.; Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol., 2018, 15(7), 387-407.
[http://dx.doi.org/10.1038/s41569-018-0007-y] [PMID: 29674714]

Negre-Salvayre, A.; Guerby, P.; Gayral, S.; Laffargue, M.; Salvayre, R. Role of reactive oxygen species in atherosclerosis: Lessons from murine genetic models. Free Radic. Biol. Med., 2020, 148, 2-22.
[http://dx.doi.org/10.1016/j.freeradbiomed.2019.10.011] [PMID: 31669759]

Libby, P. Mechanisms of acute coronary syndromes and their implications for therapy. N. Engl. J. Med., 2013, 368(21), 2004-2013.
[http://dx.doi.org/10.1056/NEJMra1216063] [PMID: 23697515]

Grootaert, M.O.J.; Roth, L.; Schrijvers, D.M.; De Meyer, G.R.Y.; Martinet, W. Defective Autophagy in Atherosclerosis: To Die or to Senesce? Oxid. Med. Cell. Longev., 2018, 2018, 7687083.
[http://dx.doi.org/10.1155/2018/7687083] [PMID: 29682164]

Huang, S.; Lu, W.; Ge, D.; Meng, N.; Li, Y.; Su, L.; Zhang, S.; Zhang, Y.; Zhao, B.; Miao, J. A new microRNA signal pathway regulated by long noncoding RNA TGFB2-OT1 in autophagy and inflammation of vascular endothelial cells. Autophagy, 2015, 11(12), 2172-2183.
[http://dx.doi.org/10.1080/15548627.2015.1106663] [PMID: 26565952]

Zhu, Y.; Yang, T.; Duan, J.; Mu, N.; Zhang, T. MALAT1/miR-15b-5p/MAPK1 mediates endothelial progenitor cells autophagy and affects coronary atherosclerotic heart disease via mTOR signaling pathway. Aging (Albany NY), 2019, 11(4), 1089-1109.
[http://dx.doi.org/10.18632/aging.101766] [PMID: 30787203]

Li, S.; Pan, X.; Yang, S.; Ma, A.; Yin, S.; Dong, Y.; Pei, H.; Bi, X.; Li, W. LncRNA MALAT1 promotes oxidized low-density lipoprotein-induced autophagy in HUVECs by inhibiting the PI3K/AKT pathway. J. Cell. Biochem., 2019, 120(3), 4092-4101.
[http://dx.doi.org/10.1002/jcb.27694] [PMID: 30485490]

Song, Z.; Wei, D.; Chen, Y.; Chen, L.; Bian, Y.; Shen, Y.; Chen, J.; Pan, Y. Association of astragaloside IV-inhibited autophagy and mineralization in vascular smooth muscle cells with lncRNA H19 and DUSP5-mediated ERK signaling. Toxicol. Appl. Pharmacol., 2019, 364, 45-54.
[http://dx.doi.org/10.1016/j.taap.2018.12.002] [PMID: 30529164]

Schulman, S.; Ageno, W.; Konstantinides, S.V. Venous thromboembolism: past, present and future. Thromb. Haemost., 2017, 117(7), 1219-1229.
[http://dx.doi.org/10.1160/TH16-10-0823] [PMID: 28594049]

Rabinovich, A.; Kahn, S.R. The postthrombotic syndrome: current evidence and future challenges. J. Thromb. Haemost., 2017, 15(2), 230-241.
[http://dx.doi.org/10.1111/jth.13569] [PMID: 27860129]

Li, W.D.; Li, X.Q. Endothelial progenitor cells accelerate the resolution of deep vein thrombosis. Vascul. Pharmacol., 2016, 83, 10-16.
[http://dx.doi.org/10.1016/j.vph.2015.07.007] [PMID: 26187355]

Simard, T.; Jung, R.G.; Motazedian, P.; Di Santo, P.; Ramirez, F.D.; Russo, J.J.; Labinaz, A.; Yousef, A.; Anantharam, B.; Pourdjabbar, A.; Hibbert, B. Progenitor cells for arterial repair: incremental advancements towards therapeutic reality. Stem Cells Int., 2017, 2017, 8270498.
[http://dx.doi.org/10.1155/2017/8270498] [PMID: 28232850]

Nussenzweig, S.C.; Verma, S.; Finkel, T. The role of autophagy in vascular biology. Circ. Res., 2015, 116(3), 480-488.
[http://dx.doi.org/10.1161/CIRCRESAHA.116.303805] [PMID: 25634971]

Li, W.D.; Zhou, D.M.; Sun, L.L.; Xiao, L.; Liu, Z.; Zhou, M.; Wang, W.B.; Li, X.Q. LncRNA WTAPP1 promotes migration and angiogenesis of endothelial progenitor cells via MMP1 through microRNA 3120 and Akt/PI3K/autophagy pathways. Stem Cells, 2018, 36(12), 1863-1874.
[http://dx.doi.org/10.1002/stem.2904] [PMID: 30171660]

Kim, J.; Guan, K.L. mTOR as a central hub of nutrient signalling and cell growth. Nat. Cell Biol., 2019, 21(1), 63-71.
[http://dx.doi.org/10.1038/s41556-018-0205-1] [PMID: 30602761]

Devaux, Y.; Zangrando, J.; Schroen, B.; Creemers, E.E.; Pedrazzini, T.; Chang, C.P.; Dorn, G.W., II; Thum, T.; Heymans, S. Cardiolinc network. Long noncoding RNAs in cardiac development and ageing. Nat. Rev. Cardiol., 2015, 12(7), 415-425.
[http://dx.doi.org/10.1038/nrcardio.2015.55] [PMID: 25855606]

Crooke, S.T. Molecular mechanisms of antisense oligonucleotides. Nucleic Acid Ther., 2017, 27(2), 70-77.
[http://dx.doi.org/10.1089/nat.2016.0656] [PMID: 28080221]

Hagedorn, P.H.; Persson, R.; Funder, E.D.; Albæk, N.; Diemer, S.L.; Hansen, D.J.; Møller, M.R.; Papargyri, N.; Christiansen, H.; Hansen, B.R.; Hansen, H.F.; Jensen, M.A.; Koch, T. Locked nucleic acid: modality, diversity and drug discovery. Drug Discov. Today, 2018, 23(1), 101-114.
[http://dx.doi.org/10.1016/j.drudis.2017.09.018] [PMID: 28988994]

Stephenson, M.L.; Zamecnik, P.C. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc. Natl. Acad. Sci. U.S.A., 1978, 75(1), 285-288.
[http://dx.doi.org/10.1073/pnas.75.1.285] [PMID: 75546]

Raal, F.J.; Santos, R.D.; Blom, D.J.; Marais, A.D.; Charng, M.J.; Cromwell, W.C.; Lachmann, R.H.; Gaudet, D.; Tan, J.L.; Chasan-Taber, S.; Tribble, D.L.; Flaim, J.D.; Crooke, S.T. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial. Lancet, 2010, 375(9719), 998-1006.
[http://dx.doi.org/10.1016/S0140-6736(10)60284-X] [PMID: 20227758]

Finkel, R.S.; Mercuri, E.; Darras, B.T.; Connolly, A.M.; Kuntz, N.L.; Kirschner, J.; Chiriboga, C.A.; Saito, K.; Servais, L.; Tizzano, E.; Topaloglu, H.; Tulinius, M.; Montes, J.; Glanzman, A.M.; Bishop, K.; Zhong, Z.J.; Gheuens, S.; Bennett, C.F.; Schneider, E.; Farwell, W.; De Vivo, D.C.; Group, E.S. ENDEAR Study Group. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med., 2017, 377(18), 1723-1732.
[http://dx.doi.org/10.1056/NEJMoa1702752] [PMID: 29091570]

Khvorova, A.; Watts, J.K. The chemical evolution of oligonucleotide therapies of clinical utility. Nat. Biotechnol., 2017, 35(3), 238-248.
[http://dx.doi.org/10.1038/nbt.3765] [PMID: 28244990]

Eckstein, F. Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them? Antisense Nucleic Acid Drug Dev., 2000, 10(2), 117-121.
[http://dx.doi.org/10.1089/oli.1.2000.10.117] [PMID: 10805163]

Vitravene Study Group. A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS. Am. J. Ophthalmol., 2002, 133(4), 467-474.
[http://dx.doi.org/10.1016/s0002-9394(02)01327-2] [PMID: 11931780]

Wilk, A.; Stec, W.J. Analysis of oligo(deoxynucleoside phosphorothioate)s and their diastereomeric composition. Nucleic Acids Res., 1995, 23(3), 530-534.
[http://dx.doi.org/10.1093/nar/23.3.530] [PMID: 7885850]

Koziolkiewicz, M.; Krakowiak, A.; Kwinkowski, M.; Boczkowska, M.; Stec, W.J. Stereodifferentiation--the effect of P chirality of oligo(nucleoside phosphorothioates) on the activity of bacterial RNase H. Nucleic Acids Res., 1995, 23(24), 5000-5005.
[http://dx.doi.org/10.1093/nar/23.24.5000] [PMID: 8559657]

Koziołkiewicz, M.; Wójcik, M.; Kobylańska, A.; Karwowski, B.; Rebowska, B.; Guga, P.; Stec, W.J. Stability of stereoregular oligo(nucleoside phosphorothioate)s in human plasma: diastereoselectivity of plasma 3′-exonuclease. Antisense Nucleic Acid Drug Dev., 1997, 7(1), 43-48.
[http://dx.doi.org/10.1089/oli.1.1997.7.43] [PMID: 9055038]

Crooke, S.T. Progress in antisense technology: the end of the beginning. Methods Enzymol., 2000, 313, 3-45.
[http://dx.doi.org/10.1016/S0076-6879(00)13003-4] [PMID: 10595347]

Prakash, T.P.; Bhat, B. 2′-Modified oligonucleotides for antisense therapeutics. Curr. Top. Med. Chem., 2007, 7(7), 641-649.
[http://dx.doi.org/10.2174/156802607780487713] [PMID: 17430205]

DeVos, S.L.; Miller, T.M. Antisense oligonucleotides: treating neurodegeneration at the level of RNA. Neurotherapeutics, 2013, 10(3), 486-497.
[http://dx.doi.org/10.1007/s13311-013-0194-5] [PMID: 23686823]

Kurreck, J. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem., 2003, 270(8), 1628-1644.
[http://dx.doi.org/10.1046/j.1432-1033.2003.03555.x] [PMID: 12694176]

Ishige, T.; Itoga, S.; Matsushita, K. Locked nucleic acid technology for highly sensitive detection of somatic mutations in cancer. Adv. Clin. Chem., 2018, 83, 53-72.
[http://dx.doi.org/10.1016/bs.acc.2017.10.002] [PMID: 29304903]

Singh, S.K.; Wengel, J. Universality of LNA-mediated high-affinity nucleic acid recognition. Chem. Commun. (Camb.), 1998, (12), 1247-1248.
[http://dx.doi.org/10.1039/a801571f]

Hughesman, C.B.; Turner, R.F.; Haynes, C.A. Role of the heat capacity change in understanding and modeling melting thermodynamics of complementary duplexes containing standard and nucleobase-modified LNA. Biochemistry, 2011, 50(23), 5354-5368.
[http://dx.doi.org/10.1021/bi200223s] [PMID: 21548576]

Kurreck, J.; Wyszko, E.; Gillen, C.; Erdmann, V.A. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res., 2002, 30(9), 1911-1918.
[http://dx.doi.org/10.1093/nar/30.9.1911] [PMID: 11972327]

Sackner-Bernstein, J. FDA approval of eteplirsen for muscular dystrophy. JAMA, 2017, 317(14), 1480-1481.
[http://dx.doi.org/10.1001/jama.2017.2597] [PMID: 28399244]

Witztum, J.L.; Gaudet, D.; Freedman, S.D.; Alexander, V.J.; Digenio, A.; Williams, K.R.; Yang, Q.; Hughes, S.G.; Geary, R.S.; Arca, M.; Stroes, E.S.G.; Bergeron, J.; Soran, H.; Civeira, F.; Hemphill, L.; Tsimikas, S.; Blom, D.J.; O’Dea, L.; Bruckert, E. Volanesorsen and triglyceride levels in familial chylomicronemia syndrome. N. Engl. J. Med., 2019, 381(6), 531-542.
[http://dx.doi.org/10.1056/NEJMoa1715944] [PMID: 31390500]

Viney, N.J.; van Capelleveen, J.C.; Geary, R.S.; Xia, S.; Tami, J.A.; Yu, R.Z.; Marcovina, S.M.; Hughes, S.G.; Graham, M.J.; Crooke, R.M.; Crooke, S.T.; Witztum, J.L.; Stroes, E.S.; Tsimikas, S. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. Lancet, 2016, 388(10057), 2239-2253.
[http://dx.doi.org/10.1016/S0140-6736(16)31009-1] [PMID: 27665230]

Graham, M.J.; Lee, R.G.; Brandt, T.A.; Tai, L.J.; Fu, W.; Peralta, R.; Yu, R.; Hurh, E.; Paz, E.; McEvoy, B.W.; Baker, B.F.; Pham, N.C.; Digenio, A.; Hughes, S.G.; Geary, R.S.; Witztum, J.L.; Crooke, R.M.; Tsimikas, S. Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides. N. Engl. J. Med., 2017, 377(3), 222-232.
[http://dx.doi.org/10.1056/NEJMoa1701329] [PMID: 28538111]

Akdim, F.; Tribble, D.L.; Flaim, J.D.; Yu, R.; Su, J.; Geary, R.S.; Baker, B.F.; Fuhr, R.; Wedel, M.K.; Kastelein, J.J. Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia. Eur. Heart J., 2011, 32(21), 2650-2659.
[http://dx.doi.org/10.1093/eurheartj/ehr148] [PMID: 21593041]

Akdim, F.; Stroes, E.S.; Sijbrands, E.J.; Tribble, D.L.; Trip, M.D.; Jukema, J.W.; Flaim, J.D.; Su, J.; Yu, R.; Baker, B.F.; Wedel, M.K.; Kastelein, J.J. Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy. J. Am. Coll. Cardiol., 2010, 55(15), 1611-1618.
[http://dx.doi.org/10.1016/j.jacc.2009.11.069] [PMID: 20378080]

Boffa, M.B.; Koschinsky, M.L. Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease. Nat. Rev. Cardiol., 2019, 16(5), 305-318.
[http://dx.doi.org/10.1038/s41569-018-0153-2] [PMID: 30675027]

Tsimikas, S.; Viney, N.J.; Hughes, S.G.; Singleton, W.; Graham, M.J.; Baker, B.F.; Burkey, J.L.; Yang, Q.; Marcovina, S.M.; Geary, R.S.; Crooke, R.M.; Witztum, J.L. Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study. Lancet, 2015, 386(10002), 1472-1483.
[http://dx.doi.org/10.1016/S0140-6736(15)61252-1] [PMID: 26210642]

Dewey, F.E.; Gusarova, V.; Dunbar, R.L.; O’Dushlaine, C.; Schurmann, C.; Gottesman, O.; McCarthy, S.; Van Hout, C.V.; Bruse, S.; Dansky, H.M.; Leader, J.B.; Murray, M.F.; Ritchie, M.D.; Kirchner, H.L.; Habegger, L.; Lopez, A.; Penn, J.; Zhao, A.; Shao, W.; Stahl, N.; Murphy, A.J.; Hamon, S.; Bouzelmat, A.; Zhang, R.; Shumel, B.; Pordy, R.; Gipe, D.; Herman, G.A.; Sheu, W.H.H.; Lee, I.T.; Liang, K.W.; Guo, X.; Rotter, J.I.; Chen, Y.I.; Kraus, W.E.; Shah, S.H.; Damrauer, S.; Small, A.; Rader, D.J.; Wulff, A.B.; Nordestgaard, B.G.; Tybjærg-Hansen, A.; van den Hoek, A.M.; Princen, H.M.G.; Ledbetter, D.H.; Carey, D.J.; Overton, J.D.; Reid, J.G.; Sasiela, W.J.; Banerjee, P.; Shuldiner, A.R.; Borecki, I.B.; Teslovich, T.M.; Yancopoulos, G.D.; Mellis, S.J.; Gromada, J.; Baras, A. Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. N. Engl. J. Med., 2017, 377(3), 211-221.
[http://dx.doi.org/10.1056/NEJMoa1612790] [PMID: 28538136]

Xu, J.; Deng, Y.; Wang, Y.; Sun, X.; Chen, S.; Fu, G. SPAG5-AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5/AKT/mTOR pathway. Cell Prolif., 2020, 53(2), e12738.
[http://dx.doi.org/10.1111/cpr.12738] [PMID: 31957155]

Zeng, R.; Song, X.J.; Liu, C.W.; Ye, W. LncRNA ANRIL promotes angiogenesis and thrombosis by modulating microRNA-99a and microRNA-449a in the autophagy pathway. Am. J. Transl. Res., 2019, 11(12), 7441-7448.
[PMID: 31934291]

Zhang, Y.F.; Li, C.S.; Zhou, Y.; Lu, X.H. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer. Life Sci., 2020, 244, 117280.
[http://dx.doi.org/10.1016/j.lfs.2020.117280] [PMID: 31926239]

Wang, I.K.; Palanisamy, K.; Sun, K.T.; Yu, S.H.; Yu, T.M.; Li, C.H.; Lin, F.Y.; Chou, A.K.; Wang, G.J.; Chen, K.B.; Li, C.Y. The functional interplay of lncRNA EGOT and HuR regulates hypoxia-induced autophagy in renal tubular cells. J. Cell. Biochem., 2020, 121(11), 4522-4534.
[http://dx.doi.org/10.1002/jcb.29669] [PMID: 32030803]

Pan, Z.; Wu, C.; Li, Y.; Li, H.; An, Y.; Wang, G.; Dai, J.; Wang, Q. LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p. Biomed. Pharmacother., 2020., 122109707.
[http://dx.doi.org/10.1016/j.biopha.2019.109707] [PMID: 31918278]

Kang, Y.; Jia, Y.; Wang, Q.; Zhao, Q.; Song, M.; Ni, R.; Wang, J. Long noncoding RNA KCNQ1OT1 promotes the progression of non-small cell lung cancer via regulating miR-204-5p/ATG3 Axis. OncoTargets Ther., 2019, 12, 10787-10797.
[http://dx.doi.org/10.2147/OTT.S226044] [PMID: 31849486]

Wang, S.; Yao, T.; Deng, F.; Yu, W.; Song, Y.; Chen, J.; Ruan, Z. LncRNA MALAT1 promotes oxygen-glucose deprivation and reoxygenation induced cardiomyocytes injury through sponging miR-20b to enhance beclin1-mediated autophagy. Cardiovasc. Drugs Ther., 2019, 33(6), 675-686.
[http://dx.doi.org/10.1007/s10557-019-06902-z] [PMID: 31823095]

Wang, L.L.; Zhang, L.; Cui, X.F. Downregulation of long noncoding RNA LINC01419 inhibits cell migration, invasion and tumor growth and promotes autophagy via inactivation of the PI3K/Akt1/mTOR pathway in gastric cancer. Ther. Adv. Med. Oncol., 2019, 11, 1758835919874651.
[http://dx.doi.org/10.1177/1758835919874651] [PMID: 31579114]

Li, P.; He, J.; Yang, Z.; Ge, S.; Zhang, H.; Zhong, Q.; Fan, X. ZNNT1 long noncoding RNA induces autophagy to inhibit tumorigenesis of uveal melanoma by regulating key autophagy gene expression. Autophagy, 2020, 16(7), 1186-1199.
[http://dx.doi.org/10.1080/15548627.2019.1659614] [PMID: 31462126]

Guo, J.; Ma, Y.; Peng, X.; Jin, H.; Liu, J. LncRNA CCAT1 promotes autophagy via regulating ATG7 by sponging miR-181 in hepatocellular carcinoma. J. Cell. Biochem., 2019, 120(10), 17975-17983.
[http://dx.doi.org/10.1002/jcb.29064] [PMID: 31218739]

Guo, Z.; Li, L.; Gao, Y.; Zhang, X.; Cheng, M. Overexpression of lncRNA ANRIL aggravated hydrogen peroxide-disposed injury in PC-12 cells via inhibiting miR-499a/PDCD4 axis-mediated PI3K/Akt/mTOR/p70S6K pathway. Artif. Cells Nanomed. Biotechnol., 2019, 47(1), 2624-2633.
[http://dx.doi.org/10.1080/21691401.2019.1629953] [PMID: 31220946]

Yu, S.; Yu, M.; He, X.; Wen, L.; Bu, Z.; Feng, J. KCNQ1OT1 promotes autophagy by regulating miR-200a/FOXO3/ATG7 pathway in cerebral ischemic stroke. Aging Cell, 2019, 18(3), e12940.
[http://dx.doi.org/10.1111/acel.12940] [PMID: 30945454]

Cai, Q.; Wang, S.; Jin, L.; Weng, M.; Zhou, D.; Wang, J.; Tang, Z.; Quan, Z. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. Mol. Cancer, 2019, 18(1), 82.
[http://dx.doi.org/10.1186/s12943-019-1016-0] [PMID: 30953511]